Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
This is an investigator-initiated, open-label, single-arm, phase II trial e...
A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis
PHASE2
This study is a prospective, single-center, open-label, exploratory phase I...
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
PHASE2
This is a two-arm, randomized, double-blinded, multicenter phase III clinic...
Status
Recruiting
Location
Center for Cancer Prevention and Treatment of Sun Yat-sen University
First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
PHASE2
This is a prospective, multi-center, randomized controlled clinical interve...
Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical Study
PHASE1
Colorectal cancer (CRC) is one of the most common malignant tumors. With th...